BioInvent Extends Research Collaboration and License Agreement With Pfizer Inc.

1. Juli 2020 INDIZES WEUR

LUND, Sweden, July 1, 2020 /PRNewswire/ — BioInvent International AB (“BioInvent” or the “Company”) (OMXS: BINV) today announces that it has further extended the research term under its cancer immuno …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs wig-20

You may also like...